Neurobo Stock Future Price Prediction

NRBO -  USA Stock  

USD 3.29  0.20  6.47%

Neurobo Pharmaceuticals stock price prediction is an act of determining the future value of Neurobo Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Neurobo Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Neurobo Pharmaceuticals and does not consider all of the tangible or intangible factors available from Neurobo Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with Neurobo Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
Additionally, see Neurobo Pharmaceuticals Basic Forecasting Models to cross-verify your projections.

Search Price Prediction 

 
Refresh
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Neurobo Pharmaceuticals based on different types of headlines from major news networks to social media. The Neurobo stock price prediction module provides an analysis of price elasticity to changes in media outlook on Neurobo Pharmaceuticals over a specific investment horizon. Using Neurobo Pharmaceuticals hype-based prediction, you can estimate the value of Neurobo Pharmaceuticals from the perspective of Neurobo Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Neurobo Pharmaceuticals. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Neurobo Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Neurobo because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Neurobo Pharmaceuticals after-hype prediction price

    
  $ 3.32  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Neurobo Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Neurobo Pharmaceuticals in the context of predictive analytics.
Intrinsic
Valuation
LowReal ValueHigh
0.326.3414.10
Details
Naive
Forecast
LowNext ValueHigh
0.073.3611.12
Details
1 Analysts
Consensus
LowTarget PriceHigh
16.0016.0016.00
Details
Earnings
Estimates (1)
LowProjected EPSHigh
-0.64-0.64-0.64
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Neurobo Pharmaceuticals. Your research has to be compared to or analyzed against Neurobo Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Neurobo Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Neurobo Pharmaceuticals.

Neurobo Pharmaceuticals After-Hype Price Prediction Density Analysis

As far as predicting the price of Neurobo Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Neurobo Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many smart people who confused the symmetrical distributions of stock prices, such as prices of Neurobo Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
 Next price density 
      Expected price to next headline 

Neurobo Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting Neurobo Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Neurobo Pharmaceuticals' historical news coverage. Neurobo Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.17 and 11.08, respectively. We have considered Neurobo Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
3.29
2nd of August 2021
3.32
After-hype Price
11.08
Upside
Neurobo Pharmaceuticals is risky asset. Analysis and calculation of next after-hype price of Neurobo Pharmaceuticals is based on 3 months time horizon.

Neurobo Pharmaceuticals Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Neurobo Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Neurobo Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Neurobo Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.30  7.76  0.03   0.53  6 Events / Month4 Events / MonthIn about 6 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
3.293.320.91 
7,760  

Neurobo Pharmaceuticals Hype Timeline

Neurobo Pharmaceuticals is now traded for 3.29. The entity has historical hype elasticity of 0.03 and average elasticity to hype of competition of 0.53. Neurobo is forecasted to increase in value after the next headline with price projected to jump to 3.32 or above. The average volatility of media hype impact on the company stock price is over 100%. The price upswing on the next news is forecasted to be 0.91% whereas the daily expected return is now at 0.3%. The volatility of related hype on Neurobo Pharmaceuticals is about 442.71% with expected price after next announcement by competition of 3.82. Net Loss for the year was (28.27 M). Given the investment horizon of 90 days the next forecastedpress releasewill be in about 6 days.
Additionally, see Neurobo Pharmaceuticals Basic Forecasting Models to cross-verify your projections.

Neurobo Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Neurobo Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Neurobo Pharmaceuticals' future price movements. Getting to know how Neurobo Pharmaceuticals rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Neurobo Pharmaceuticals may potentially react to the hype associated with one of its peers.

Neurobo Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Neurobo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Neurobo using various technical indicators. When you analyze Neurobo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Neurobo Pharmaceuticals Predictive Indicators

The successful prediction of Neurobo Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Neurobo Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Neurobo Pharmaceuticals based on analysis of Neurobo Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Neurobo Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Neurobo Pharmaceuticals's related companies.

Story Coverage note for Neurobo Pharmaceuticals

The number of cover stories for Neurobo Pharmaceuticals depends on current market conditions and Neurobo Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Neurobo Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Neurobo Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Contributor Headline

Latest Perspective on Neurobo Pharmaceuticals

Neurobo Pharmaceuticals Short Properties

Neurobo Pharmaceuticals' future price predictability will typically decrease when Neurobo Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Neurobo Pharmaceuticals often depends not only on the future outlook of the potential Neurobo Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Neurobo Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out1.82%
Short Percent Of Float4.30%
Float Shares6.34M
Shares Short Prior Month359.3k
Average Daily Volume Last 10 Day1.32M
Average Daily Volume In Three Month2.47M
Date Short Interest28th of May 2021
Additionally, see Neurobo Pharmaceuticals Basic Forecasting Models to cross-verify your projections. Note that the Neurobo Pharmaceuticals information on this page should be used as a complementary analysis to other Neurobo Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Complementary Tools for Neurobo Stock analysis

When running Neurobo Pharmaceuticals price analysis, check to measure Neurobo Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurobo Pharmaceuticals is operating at the current time. Most of Neurobo Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Neurobo Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Neurobo Pharmaceuticals' price. Additionally, you may evaluate how the addition of Neurobo Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
The market value of Neurobo Pharmaceuticals is measured differently than its book value, which is the value of Neurobo that is recorded on the company's balance sheet. Investors also form their own opinion of Neurobo Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Neurobo Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neurobo Pharmaceuticals' market value can be influenced by many factors that don't directly affect Neurobo Pharmaceuticals underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neurobo Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Neurobo Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neurobo Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.